Schedule 13G ownership disclosure

INTRA-CELLULAR THERAPIES INC

Security class unavailable · CUSIP: 46116X101

Event date: 2022-12-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,409,685
Percent of class
5.7100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000846087-23-000127
Form type
SC 13G
Filer
Intra-Cellular Therapies, Inc.
CIK
CIK 1567514
Filed
Feb 06, 2023
Reporting period
Dec 30, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub